Highlights
IIA supported (ever)
About
Diagnosis of Inflammatory Bowel Diseases
Tracells specializes in non-invasive diagnostic testing for inflammatory bowel diseases (IBD) using advanced RNA transcriptomics and AI-driven classifiers. Their stool tests utilize RNA profiles from intestinal cells to accurately diagnose IBD, assess inflammation severity and location, and predict therapy response. This method aims to replace invasive procedures like endoscopies with a convenient, home-based testing alternative, offering precise, cost-effective monitoring and disease management.
Identity
| Name | Tracells |
|---|---|
| Slug | tracells |
| Type / kind | startup |
| Source _id | rp4YmcTJpAAoepgJn3y3QRoTidqFT7ycX6NPmRdSkOdxVsUGRPXBVa |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Yokne'am Illit |
| HQ address | Yokne'am Illit, Israel |
Web & social
| Website | https://www.tracells.com/ |
|---|---|
| https://www.linkedin.com/company/101528832 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyTest Diagnostics & Screening
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business models
B2B
Tags
pharmaceuticalsnon-invasivediagnosticsinflammatory-diseases
Funding
| Total raised | $1.0M |
|---|---|
| Current stage | Pre-Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}